Munafa Stock Market Course + Intraday & FNO calls 
PY NEWS why is Principal Shareholder Yield Index Etf price falling or rising
PY NEWS reasons for why stock price of Principal Shareholder Yield Index Etf is falling or rising
PY Principal Shareholder is falling or rising technical reasons
Technical analysis forecast of Principal Shareholder Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Principal Shareholder PY at this time. Stock is rising and might rise more.
It appears as if Principal Shareholder PY gave a large move recently.
Stock of Principal Shareholder (PY) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Principal Shareholder is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Principal Shareholder stays above 52.2, but if it comes below 52.2, then a intra day sell could be more profitable.
If you take a sell trade below 52.2, then use 52.2 as stoploss and 51.6 as target. However if you take a buy trade in Principal Shareholder, then use 52.2 as stoploss and 52.9 as target.
PY Principal Shareholder is falling or rising NEWS fundamental reasons
Meesho protest: Why Samir Arora and Sandip Sabharwal are unhappy with how IPO anchors are chosen Several global and domestic funds withdrew from Meesho's anchor book, citing dissatisfaction with share allocation, particularly SBI Mutual Fund's large portion. Market commentators Samir Arora and Sandip Sabharwal have raised concerns, suggesting reforms - NEWS as on 2025-12-03 indiatimes.com
BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi (Revised) Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications. - NEWS as on 2025-11-27 nasdaq.com
Glenmark launches fixed-dose triple therapy for COPD Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three medicines to improve lung function and symptom control. It offers a new standard of care, especially for patients wh - NEWS as on 2025-11-25 indiatimes.com
US FDA approves Novartis' gene therapy for rare muscle disorder The US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma offers a new option for a broader patient group. The therapy aims to replace a faulty gene crucial for muscle functi - NEWS as on 2025-11-25 indiatimes.com
More announcements and NEWS
PY Principal Shareholder Yield Index Etf current price & indicator signals
Recent prices of PY Principal Shareholder Yield Index Etf are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 04 Thu Dec 2025 | 52.36 | 52.36 to 52.51 | 0.15% | 0.66 times |
| 03 Wed Dec 2025 | 52.28 | 52.08 to 52.33 | 0.71% | 1.16 times |
| 02 Tue Dec 2025 | 51.91 | 51.74 to 52.02 | 0.04% | 0.6 times |
| 01 Mon Dec 2025 | 51.89 | 51.89 to 52.22 | -0.21% | 0.87 times |
| 28 Fri Nov 2025 | 52.00 | 51.80 to 52.08 | 0.29% | 1.14 times |
| 26 Wed Nov 2025 | 51.85 | 51.80 to 52.01 | 0.5% | 1.01 times |
| 25 Tue Nov 2025 | 51.59 | 51.20 to 51.63 | 1.1% | 1.04 times |
| 24 Mon Nov 2025 | 51.03 | 50.89 to 51.15 | 0.26% | 0.73 times |
| 21 Fri Nov 2025 | 50.90 | 50.55 to 51.23 | 1.56% | 0.8 times |
| 20 Thu Nov 2025 | 50.12 | 50.08 to 51.21 | -0.85% | 0.82 times |
| 19 Wed Nov 2025 | 50.55 | 50.43 to 50.70 | -0.28% | 1.83 times |
| 18 Tue Nov 2025 | 50.69 | 50.42 to 50.89 | 0.12% | 1.3 times |
Videos related to: PY NEWS why is Principal Shareholder Yield Index Etf price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
